Our present findings provide novel pathological insights into Wnt3a signaling in the progression of CIN and aggressiveness of cervical cancer, thus defining a potential therapeutic target for cervical lesions. The gene discussed is WNT3A; the disease is cervical squamous intraepithelial neoplasia.